PL1601450T3 - Ciekły preparat tkankowy z próbek biologicznych, tkanek i komórek poddanych obróbce histopatologicznej - Google Patents

Ciekły preparat tkankowy z próbek biologicznych, tkanek i komórek poddanych obróbce histopatologicznej

Info

Publication number
PL1601450T3
PL1601450T3 PL04719188T PL04719188T PL1601450T3 PL 1601450 T3 PL1601450 T3 PL 1601450T3 PL 04719188 T PL04719188 T PL 04719188T PL 04719188 T PL04719188 T PL 04719188T PL 1601450 T3 PL1601450 T3 PL 1601450T3
Authority
PL
Poland
Prior art keywords
histopatologically
tissues
cells
biological samples
tissue preparation
Prior art date
Application number
PL04719188T
Other languages
English (en)
Inventor
Marlene M Darfler
David B Krizman
Original Assignee
Expression Pathology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expression Pathology Inc filed Critical Expression Pathology Inc
Publication of PL1601450T3 publication Critical patent/PL1601450T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4044—Concentrating samples by chemical techniques; Digestion; Chemical decomposition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/44—Sample treatment involving radiation, e.g. heat
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
PL04719188T 2003-03-10 2004-03-10 Ciekły preparat tkankowy z próbek biologicznych, tkanek i komórek poddanych obróbce histopatologicznej PL1601450T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45295603P 2003-03-10 2003-03-10
EP04719188.7A EP1601450B1 (en) 2003-03-10 2004-03-10 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
PCT/US2004/007142 WO2004080579A2 (en) 2003-03-10 2004-03-10 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells

Publications (1)

Publication Number Publication Date
PL1601450T3 true PL1601450T3 (pl) 2014-03-31

Family

ID=32990709

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04719188T PL1601450T3 (pl) 2003-03-10 2004-03-10 Ciekły preparat tkankowy z próbek biologicznych, tkanek i komórek poddanych obróbce histopatologicznej

Country Status (9)

Country Link
US (5) US7473532B2 (pl)
EP (1) EP1601450B1 (pl)
JP (1) JP4579234B2 (pl)
CA (1) CA2518569C (pl)
DK (1) DK1601450T3 (pl)
ES (1) ES2428941T3 (pl)
PL (1) PL1601450T3 (pl)
PT (1) PT1601450E (pl)
WO (1) WO2004080579A2 (pl)

Families Citing this family (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7641780B2 (en) * 2001-05-01 2010-01-05 Calibrant Biosystems, Inc. Two-dimensional microfluidics for protein separations and gene analysis
PT1601450E (pt) * 2003-03-10 2013-09-06 Expression Pathology Inc Preparação líquida de tecido a partir de amostras biológicas, de tecidos e de células tratados histopatologicamente
US7381440B2 (en) * 2003-06-06 2008-06-03 The United States Of America As Represented By The Secretary Of The Navy Biological laser printing for tissue microdissection via indirect photon-biomaterial interactions
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
DE102005023011A1 (de) * 2005-05-19 2006-11-23 Qiagen Gmbh Quantitative Proteinbestimmung von Formalin fixiertem Gewebe
WO2006127861A2 (en) * 2005-05-25 2006-11-30 Expression Pathology, Inc. Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
US7906301B2 (en) * 2005-05-25 2011-03-15 Expression Pathology, Inc. Multiplex method for increased proteomic coverage from histopathologically processed biological samples, tissues cells
EP1910389A4 (en) * 2005-05-31 2010-03-10 Life Technologies Corp SEPARATION AND PURIFICATION OF NUCLEIC ACID FROM PARAFFIN-SAMPLE SAMPLES
DE102005027172A1 (de) 2005-06-13 2006-12-14 Merck Patent Gmbh Verwendung von Ionischen Flüssigkeiten zur Proteinextraktion
US20110177492A1 (en) * 2005-06-16 2011-07-21 3M Innovative Properties Company Method of classifying chemically crosslinked cellular samples using mass spectra
DE102005060738A1 (de) * 2005-12-16 2007-06-21 Qiagen Gmbh Verfahren zur Extraktion von Biomolekülen aus fixierten Geweben
WO2007112350A2 (en) * 2006-03-24 2007-10-04 Expression Pathology Method of assessing the metastatic status of a primary tumor
JP2008043332A (ja) * 2006-08-17 2008-02-28 Panomics Inc 組織スライドからの核酸定量
JPWO2008038813A1 (ja) * 2006-09-28 2010-01-28 株式会社島津製作所 パラフィン包埋標本の脱パラフィン法及びパラフィン包埋標本の解析法
US20080156080A1 (en) * 2007-01-02 2008-07-03 Calibrant Biosystems, Inc. Methods and systems for multidimensional concentration and separation of biomolecules using capillary isotachophoresis
US20080160629A1 (en) * 2007-01-02 2008-07-03 Calibrant Biosystems, Inc. Methods and systems for off-line multidimensional concentration and separation of biomolecules
JP2010533563A (ja) 2007-07-19 2010-10-28 ボストン サイエンティフィック リミテッド 吸着抑制表面を有する内部人工器官
JP2010535541A (ja) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド 広い表面積を有する医療器具用のコーティング
WO2009131911A2 (en) 2008-04-22 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
EP2193831A1 (de) 2008-12-05 2010-06-09 Qiagen GmbH Parallel-Extraktion von unterschiedlichen Biomolekülen aus Formalin-fixiertem Gewebe
DE202009018981U1 (de) 2009-07-01 2015-03-11 Axagarius Gmbh & Co. Kg Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit dafür
EP2517002B1 (en) 2009-12-22 2017-08-02 Expression Pathology, Inc. Insulin receptor substrate 1 (irs1) protein srm/mrm assay
EP2517010B1 (en) * 2009-12-22 2019-06-05 Expression Pathology, Inc. Epidermal growth factor receptor (egfr) protein srm/mrm assay
DK2517011T3 (en) * 2009-12-22 2015-11-23 Expression Pathology Inc SRM / MRM analysis for the receptor protein for the insulin-like growth factor 1 (IGF-1R)
AU2010341489A1 (en) * 2009-12-22 2012-07-19 Expression Pathology, Inc. Secreted Protein Acidic and Rich in Cysteine (SPARC) protein SRM/MRM assay
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
AU2011258152A1 (en) * 2010-05-26 2013-01-10 Expression Pathology, Inc. Urokinase-type plasminogen activator protein/plasminogen activator inhibitor type-1 protein-selected reaction monitoring assay
EP2601519B1 (en) * 2010-07-30 2017-12-06 Expression Pathology, Inc. C-src selected reaction monitoring assay
WO2012048335A2 (en) 2010-10-08 2012-04-12 The University Of North Carolina At Chapel Hill Formulation of acoustically activatable particles having low vaporization energy and methods for using same
WO2012092302A1 (en) 2010-12-27 2012-07-05 Expression Pathology, Inc. Cmet protein srm/mrm assay
AU2012205337B2 (en) * 2011-01-13 2017-04-13 Expression Pathology, Inc. Bcl-2-like protein 11 SRM/MRM assay
CN102146112B (zh) * 2011-01-25 2013-07-10 天根生化科技（北京）有限公司 从福尔马林固定石蜡包埋组织中提取脱氧核糖核酸的方法
US9372196B2 (en) 2011-03-08 2016-06-21 Bioproximity, Llc Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
EP2758779B1 (en) 2011-09-22 2017-09-06 Expression Pathology, Inc. Mrm/srm assay for death receptor 5 protein
CA2849301C (en) 2011-09-22 2019-07-30 Expression Pathology, Inc. Multiplex mrm assay for evaluation of cancer
ES2670651T3 (es) 2011-10-04 2018-05-31 Expression Pathology, Inc. Ensayo de SRM/MRM para determinar la proteína ERBB-4 del receptor de tirosina-proteína quinasa (HER4)
EP2788484B1 (en) * 2011-12-06 2017-11-01 Qiagen GmbH Recovery of a biomolecule comprising aqueous phase from a multiphasic mixture
CA2862834C (en) * 2012-01-10 2020-06-16 David B. Krizman Srm/mrm assay for the insulin receptor protein
CN103207107B (zh) * 2012-01-16 2016-09-07 中国医学科学院北京协和医院 硝酸纤维素膜富集体液蛋白质组蛋白的用途
AU2013262727B2 (en) 2012-05-16 2017-07-27 Expression Pathology, Inc. SRM/MRM assay for subtyping lung histology
WO2014055832A1 (en) * 2012-10-04 2014-04-10 The University Of North Carolina At Chapel Hill Methods and systems for using encapsulated microbubbles to process biological samples
EP3901280B1 (en) 2012-10-17 2025-03-12 10x Genomics Sweden AB Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
EP2730653A1 (en) 2012-11-07 2014-05-14 QIAGEN GmbH Method for lysing a fixed biological sample
CN105229164B (zh) 2013-03-15 2019-02-12 爱科谱迅病理研究公司 指示癌症疗法的srm测定
CN111500680B (zh) 2013-06-25 2024-04-16 普罗格诺西斯生物科学公司 检测样品中生物靶标的空间分布的方法和系统
WO2015103645A2 (en) 2014-01-06 2015-07-09 Expression Pathology, Inc. Srm assay for pd-l1
KR20160149258A (ko) * 2014-04-30 2016-12-27 익스프레션 패톨로지, 인크. 안드로겐 수용체(ar) 단백질에 대한 srm/mrm 검정
WO2015168484A1 (en) * 2014-04-30 2015-11-05 Expression Pathlogy, Inc. Srm/mrm assay for the tyrosine-protein kinase receptor ufo (axl) protein
CN107110840A (zh) 2014-07-01 2017-08-29 爱科谱迅病理研究公司 针对化疗靶标的srm测定
CA2954692A1 (en) * 2014-07-11 2016-01-14 Expression Pathology, Inc. Srm/mrm assay for the gtpase kras protein (kras)
US20190099475A1 (en) 2015-04-08 2019-04-04 Nantomics, Llc Cancer neoepitopes
EP4321627A3 (en) 2015-04-10 2024-04-17 10x Genomics Sweden AB Spatially distinguished, multiplex nucleic acid analysis of biological specimens
CA3172682A1 (en) 2015-04-23 2016-10-27 Nantomics, Llc Cancer neoepitopes
WO2016183595A1 (en) 2015-05-14 2016-11-17 Expression Pathology, Inc. Srm/mrm assay for the 6-o-methylguanine-dna methyltransferase (mgmt) protein
JP2018517136A (ja) * 2015-05-14 2018-06-28 エクスプレッション、パソロジー、インコーポレイテッドＥｘｐｒｅｓｓｉｏｎ Ｐａｔｈｏｌｏｇｙ， Ｉｎｃ． 線維芽細胞増殖因子受容体２（ｆｇｆｒ２）タンパク質のためのｓｒｍ／ｍｒｍアッセイ
EP3295180B1 (en) 2015-05-14 2020-07-22 Expression Pathology, Inc. Srm/mrm assay for the mesothelin (msln) protein
CA2986730C (en) 2015-05-22 2020-04-14 Expression Pathology, Inc. Srm/mrm assay for the cyclin-dependent kinase inhibitor 2a (p16) protein
JP6524266B2 (ja) 2015-05-29 2019-06-05 エクスプレッション、パソロジー、インコーポレイテッドＥｘｐｒｅｓｓｉｏｎ Ｐａｔｈｏｌｏｇｙ， Ｉｎｃ． 最適な癌療法のためのＨｅｒ２タンパク質の定量化
CA2994167A1 (en) 2015-07-30 2017-02-02 Expression Pathology, Inc. Quantifying fr-a and gart proteins for optimal cancer therapy
EP3352859B1 (en) 2015-09-24 2020-09-23 Expression Pathology, Inc. Quantifying met protein for cancer treatment
AU2016339035A1 (en) 2015-10-12 2018-05-10 Nantomics, Llc Systems, compositions, and methods for discovery of MSI and neoepitopes that predict sensitivity to checkpoint inhibitors
KR20180087246A (ko) 2015-10-12 2018-08-01 난토믹스, 엘엘씨 네오에피토프의 반복적 발견 및 이에 대한 적응성 면역치료 및 방법
CN108601820A (zh) 2015-10-12 2018-09-28 南托米克斯有限责任公司 用于病毒癌症新表位的组合物和方法
WO2017066290A1 (en) 2015-10-12 2017-04-20 Nantomics, Llc Viral neoepitopes and uses thereof
TWI733719B (zh) 2015-12-07 2021-07-21 美商河谷控股Ｉｐ有限責任公司 改善的組合物及用於新表位之病毒遞送的方法及其應用
CN108701172A (zh) 2016-02-12 2018-10-23 南托米克斯有限责任公司 高通量识别患者特异性新表位作为癌症免疫疗法的治疗靶点
ES2802453T3 (es) * 2016-03-24 2021-01-19 Allflex Europe Sa Uso de una composición acuosa para la disolución de biomoléculas de una muestra de tejido
JP2019513021A (ja) 2016-03-24 2019-05-23 ナントセル，インコーポレイテッド ネオエピトープ提示のための配列の配置および配列
WO2017184905A1 (en) * 2016-04-20 2017-10-26 Expression Pathology, Inc. Method for improved hepatocellular cancer diagnosis
WO2017202962A1 (en) 2016-05-24 2017-11-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
US12635974B2 (en) 2016-07-15 2026-05-26 The Regents Of The University Of Michigan Methods and systems for using phase change nanodroplets to enhance sonothrombolysis
AU2017315468B2 (en) 2016-08-25 2020-02-13 Nantomics, Llc Immunotherapy markers and uses therefor
US20190321481A1 (en) 2016-11-11 2019-10-24 Nantbio, Inc. Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
WO2018102613A2 (en) 2016-12-01 2018-06-07 Nantomics, Llc Tumor antigenicity processing and presentation
WO2018102827A1 (en) 2016-12-04 2018-06-07 Expression Pathology, Inc. Improved methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
WO2018122249A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
WO2018122245A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
WO2018160988A1 (en) * 2017-03-03 2018-09-07 Expression Pathology, Inc. Immune profiling of tumor tissue
CA3061240C (en) 2017-04-24 2024-01-16 Nantcell, Inc. Targeted neoepitope vectors and methods therefor
US20200150109A1 (en) 2017-05-05 2020-05-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
WO2018222433A2 (en) 2017-05-30 2018-12-06 Nant Holdings Ip, Llc Circulating tumor cell enrichment using neoepitopes
EP3688165A4 (en) 2017-09-25 2021-09-29 Nant Holdings IP, LLC VALIDATION OF THE PRESENTATION OF NEOEPITOPES
US10722509B2 (en) * 2018-01-16 2020-07-28 Nantomics, Llc Predicting optimal chemotherapy for CRC
US10725045B2 (en) 2018-02-13 2020-07-28 Nantomics, Llc Quantifying MGMT protein for optimal cancer therapy of glioblastoma
US10722531B2 (en) 2018-02-13 2020-07-28 Nantomics, Llc OPRT expression and cancer treatment outcome
AU2019201463A1 (en) 2018-03-09 2019-09-26 Nantomics, Llc Srm/mrm assays for profiling tumor tissue
US20190353660A1 (en) 2018-05-17 2019-11-21 Nantomics, Llc Identification of cancer patients sensitive or resistant to 5-fluorouracil (5-fu)
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
US12487240B2 (en) 2018-10-11 2025-12-02 Nantomics, Llc Tumor HLA mutation versus matched normal HLA
KR20200050374A (ko) 2018-10-30 2020-05-11 익스프레션 패톨로지, 인크. 노치 경로 단백질용 srm/mrm 분석
EP3894585A2 (en) 2018-12-10 2021-10-20 10X Genomics, Inc. Generating capture probes for spatial analysis
US12529094B2 (en) 2018-12-10 2026-01-20 10X Genomics, Inc. Imaging system hardware
MX2021008121A (es) 2019-01-03 2021-12-10 Inst Nat Sante Rech Med Metodos y composiciones farmaceuticas para mejorar las respuestas inmunitarias dependientes de celulas t cd8+ en sujetos que sufren de cancer.
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
KR20200087700A (ko) 2019-01-11 2020-07-21 난토믹스, 엘엘씨 질량 분석법에 의한 sdhb 단백질 발현의 평가
WO2020201362A2 (en) 2019-04-02 2020-10-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions
US20220160692A1 (en) 2019-04-09 2022-05-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer
EP3976820A1 (en) 2019-05-30 2022-04-06 10X Genomics, Inc. Methods of detecting spatial heterogeneity of a biological sample
CN114072676B (zh) 2019-06-03 2024-07-12 法国国家卫生及研究医学协会 调节治疗方案的方法
JP7215467B2 (ja) * 2019-08-19 2023-01-31 株式会社島津製作所 ホルマリン固定パラフィン包埋組織試料からの抗体の分離、検出及び／又は分析方法
EP4045686A1 (en) 2019-10-17 2022-08-24 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for diagnosing nasal intestinal type adenocarcinomas
WO2021076036A1 (en) 2019-10-18 2021-04-22 Reccan Diagnostics Ab Apparatuses and methods for detection of pancreatic cancer
EP4025711A2 (en) 2019-11-08 2022-07-13 10X Genomics, Inc. Enhancing specificity of analyte binding
EP4752521A3 (en) 2019-12-23 2026-08-12 10X Genomics, Inc. Reversible fixing reagents and methods of use thereof
EP4081656A1 (en) 2019-12-23 2022-11-02 10X Genomics, Inc. Compositions and methods for using fixed biological samples in partition-based assays
CN121022991A (zh) 2019-12-23 2025-11-28 10X基因组学有限公司 使用rna模板化连接进行空间分析的方法
US12365942B2 (en) 2020-01-13 2025-07-22 10X Genomics, Inc. Methods of decreasing background on a spatial array
US12405264B2 (en) 2020-01-17 2025-09-02 10X Genomics, Inc. Electrophoretic system and method for analyte capture
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US20210230681A1 (en) 2020-01-24 2021-07-29 10X Genomics, Inc. Methods for spatial analysis using proximity ligation
US12076701B2 (en) 2020-01-31 2024-09-03 10X Genomics, Inc. Capturing oligonucleotides in spatial transcriptomics
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US12110541B2 (en) 2020-02-03 2024-10-08 10X Genomics, Inc. Methods for preparing high-resolution spatial arrays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US12129516B2 (en) 2020-02-07 2024-10-29 10X Genomics, Inc. Quantitative and automated permeabilization performance evaluation for spatial transcriptomics
US12281357B1 (en) 2020-02-14 2025-04-22 10X Genomics, Inc. In situ spatial barcoding
CN116157533A (zh) 2020-02-21 2023-05-23 10X基因组学有限公司 使用杂交方法捕获遗传靶标
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
US11926863B1 (en) 2020-02-27 2024-03-12 10X Genomics, Inc. Solid state single cell method for analyzing fixed biological cells
WO2021170777A1 (en) 2020-02-28 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing, prognosing and managing treatment of breast cancer
EP4127164A1 (en) 2020-03-31 2023-02-08 QIAGEN GmbH Nucleic acid purification from fixed biological samples
WO2021207610A1 (en) 2020-04-10 2021-10-14 10X Genomics, Inc. Cold protease treatment method for preparing biological samples
WO2021212042A1 (en) 2020-04-16 2021-10-21 10X Genomics, Inc. Compositions and methods for use with fixed samples
EP4139485B1 (en) 2020-04-22 2023-09-06 10X Genomics, Inc. Methods for spatial analysis using targeted rna depletion
AU2021275906A1 (en) 2020-05-22 2022-12-22 10X Genomics, Inc. Spatial analysis to detect sequence variants
EP4153775B1 (en) 2020-05-22 2024-07-24 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
EP4421186B1 (en) 2020-06-08 2025-08-13 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
EP4450639B1 (en) 2020-06-25 2025-10-15 10X Genomics, Inc. Spatial analysis of dna methylation
EP4172621A1 (en) 2020-06-30 2023-05-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
JP7741831B2 (ja) 2020-06-30 2025-09-18 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 術前補助療法及び根治手術後の固形がんを患っている患者の再発及び／又は死亡のリスクを予測するための方法
US12209280B1 (en) 2020-07-06 2025-01-28 10X Genomics, Inc. Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
EP4189110A1 (en) 2020-07-31 2023-06-07 10X Genomics, Inc. De-crosslinking compounds and methods of use for spatial analysis
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
WO2022103712A1 (en) 2020-11-13 2022-05-19 10X Genomics, Inc. Nano-partitions (encapsulated nucleic acid processing enzymes) for cell-lysis and multiple reactions in partition-based assays
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
WO2022140028A1 (en) 2020-12-21 2022-06-30 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
KR20240012352A (ko) 2021-03-23 2024-01-29 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) T 세포 림프종의 진단 및 치료 방법
EP4305196B1 (en) 2021-04-14 2025-04-02 10X Genomics, Inc. Methods of measuring mislocalization of an analyte
EP4320271B1 (en) 2021-05-06 2025-03-19 10X Genomics, Inc. Methods for increasing resolution of spatial analysis
ES3030033T3 (en) 2021-06-03 2025-06-26 10X Genomics Inc Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis
WO2023034489A1 (en) 2021-09-01 2023-03-09 10X Genomics, Inc. Methods, compositions, and kits for blocking a capture probe on a spatial array
EP4419707A1 (en) 2021-11-10 2024-08-28 10X Genomics, Inc. Methods, compositions, and kits for determining the location of an analyte in a biological sample
EP4305195A2 (en) 2021-12-01 2024-01-17 10X Genomics, Inc. Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis
WO2023121449A1 (en) 2021-12-21 2023-06-29 Koninklijke Nederlandse Akademie Van Wetenschappen Central nervous system organoids
WO2023144303A1 (en) 2022-01-31 2023-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Cd38 as a biomarker and biotarget in t-cell lymphomas
US20250035635A1 (en) 2022-03-17 2025-01-30 Institut National De La Sante Et De La Recherche Medicale Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
WO2023198648A1 (en) 2022-04-11 2023-10-19 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of t-cell malignancies
WO2023198874A1 (en) 2022-04-15 2023-10-19 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of t cell-lymphomas
JP7867373B2 (ja) * 2022-05-12 2026-05-29 株式会社日立製作所 タンパク質の分析方法
US20240035071A1 (en) 2022-06-17 2024-02-01 10X Genomics, Inc. Catalytic de-crosslinking of samples for in situ analysis
WO2024003310A1 (en) 2022-06-30 2024-01-04 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of acute lymphoblastic leukemia
US20260029402A1 (en) 2022-07-22 2026-01-29 Institut National de la Santé et de la Recherche Médicale Garp as a biomarker and biotarget in t-cell malignancies
WO2024023283A1 (en) 2022-07-29 2024-02-01 Institut National de la Santé et de la Recherche Médicale Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
WO2024079192A1 (en) 2022-10-12 2024-04-18 Institut National de la Santé et de la Recherche Médicale Cd81 as a biomarker and biotarget in t-cell malignancies
EP4685239A1 (en) 2022-11-09 2026-01-28 10X Genomics, Inc. Methods, compositions, and kits for determining the location of multiple analytes in a biological sample

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162504A (en) * 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5225325A (en) * 1990-03-02 1993-07-06 Ventana Medical Systems, Inc. Immunohistochemical staining method and reagents therefor
US5422261A (en) * 1993-04-16 1995-06-06 Baxter International Inc. Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells
US5843657A (en) * 1994-03-01 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Isolation of cellular material under microscopic visualization
US6251467B1 (en) * 1994-03-01 2001-06-26 The United States Of America As Represented By The Department Of Health And Human Services Isolation of cellular material under microscopic visualization
JP3125633B2 (ja) * 1994-07-06 2001-01-22 和光純薬工業株式会社 遺伝子分析用試料としてのパラフィン包埋組織標本の処理方法及び処理用キット
CA2153215A1 (en) * 1994-07-06 1996-01-07 Lu Wang Treatment of paraffin embedded tissue for gene analysis
US6274309B1 (en) * 1996-07-26 2001-08-14 Richard Kolesnick Method for the modulation of acid-sphingomyelinase-related apoptosis
US6573043B1 (en) * 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
US6469159B1 (en) * 1999-04-26 2002-10-22 Robert T. Belly Methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues
US6248535B1 (en) * 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
DE19963198B4 (de) 1999-12-27 2004-12-30 Schulz-Schaeffer, Walter, Dr. Verfahren zum topographischen Proteinnachweis an formalinfixierten Gewebeschnitten
US7001724B1 (en) * 2000-11-28 2006-02-21 Applera Corporation Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
GB2369822A (en) 2000-12-05 2002-06-12 Genovar Diagnostics Ltd Nucleic acid extraction method and kit
US20050164388A1 (en) * 2001-02-07 2005-07-28 Young-Sook Son Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells and preconditioned cells
US6833270B2 (en) * 2001-11-27 2004-12-21 Biorep Technologies, Inc. Apparatus and method for isolating cells from organs
WO2003064605A2 (en) * 2002-01-28 2003-08-07 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
DE10306237A1 (de) 2003-02-14 2004-09-02 Daimlerchrysler Ag Verfahren zum Steuern eines Brennstoffzellensystems und Anordnungen zur Durchführung des Vefahrens
US20040161845A1 (en) * 2003-02-14 2004-08-19 Poo Ramon E. Heating apparatus
PT1601450E (pt) * 2003-03-10 2013-09-06 Expression Pathology Inc Preparação líquida de tecido a partir de amostras biológicas, de tecidos e de células tratados histopatologicamente
WO2005054466A2 (en) * 2003-07-25 2005-06-16 Ambion, Inc. Methods and compositions for preparing rna from a fixed sample
US8012693B2 (en) * 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples

Also Published As

Publication number Publication date
EP1601450A4 (en) 2007-10-10
US20130252840A1 (en) 2013-09-26
DK1601450T3 (da) 2013-09-08
EP1601450A2 (en) 2005-12-07
US9163275B2 (en) 2015-10-20
US20160018304A1 (en) 2016-01-21
JP2006519996A (ja) 2006-08-31
US20190368986A1 (en) 2019-12-05
US20050014203A1 (en) 2005-01-20
US8455215B2 (en) 2013-06-04
CA2518569C (en) 2011-11-15
US10444126B2 (en) 2019-10-15
PT1601450E (pt) 2013-09-06
CA2518569A1 (en) 2004-09-23
WO2004080579A2 (en) 2004-09-23
US20090197776A1 (en) 2009-08-06
JP4579234B2 (ja) 2010-11-10
US7473532B2 (en) 2009-01-06
WO2004080579A3 (en) 2005-03-31
ES2428941T3 (es) 2013-11-12
EP1601450B1 (en) 2013-06-05

Similar Documents

Publication Publication Date Title
DK1601450T3 (da) Flydende vævspræparat ud fra histopatologisk bearbejdede biologiske prøver, væv og celler
GB2423151B (en) Examination systems for biological samples
GB2399291B (en) Electrode rod for treating biological tissue
GB2412913B (en) Compositions and methods for preserving rna in biological samples
PL1641914T3 (pl) Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
AU2002232104A1 (en) Syringe for use in blood analysis
AU2011202385A1 (en) Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
EP1671594A4 (en) MEDICAL CLAMP TYPE DEVICE, MEDICAL INSTRUMENT, AND METHOD FOR CUTTING ORGAN TISSUE USING THE DEVICE
IL184587A0 (en) Systems, methods, and compositions for detection of human papilloma virus in biological samples
EP1547529A4 (en) DEVICE FOR LIGATURING BIOLOGICAL TISSUE
EP1883705A4 (en) MULTIPLEX PROCESS FOR INCREASING PROTEOMIC COVERAGE FROM HISTOPATHOLOGICALLY TREATED BIOLOGICAL SAMPLES USING LIQUID TISSUE PREPARATIONS
EP1802756A4 (en) PROBE OF HUMAN PAPILLOMA AND THIS COMPREHENSIVE DNA CHIP
AU2003203378A1 (en) Suture insrument for biological use
EP1581646A3 (en) Extraction of dna from biological samples
AU2003249106A8 (en) Method and apparatus for analyzing biological tissues
EP1651760A4 (en) HUMAN BLOOD PROTEINS EXPRESSED IN MONOCOTYLEDONE SEEDS
AU2003286510A1 (en) Blood vessel harvesting device
AU2003281309A1 (en) Novel undifferentiated stem cells contained in cord blood, bone marrow, peripheral blood or the like
AU2003242360A1 (en) Culture apparatus, artificial tissue and blood preparation
EP1415601B8 (en) Blood vessel knife
WO2004087876A3 (en) Use of red blood cells to facilitate cell activation
EP1648488A4 (en) EXPRESSED MEMBRANE PROTEIN IN HUMAN MAST CELLS
AU2003225684A1 (en) Multi-fiber catheter probe arrangement for tissue analysis or treatment
AU2003263142A1 (en) Method and device for the non-invasive determination of the temperature in biological tissue
WO2004084705A9 (en) Quantitative detection of h. pylori in biological samples